Conversely, LAT2 expression was associated with poorer survival in pancreatic cancer and was indicated to play a role in the pathogenesis of glomerulonephritis, both through LAT2-mediated mTOR activation (Kurayama et al., 2011; Feng et al., 2018). This evidence concerns the gene LAT2 and pancreatic neoplasm.